CRISPR-Cas9: A method for establishing rat models of drug metabolism and pharmacokinetics - ScienceDirect

Pharmaceutics, Free Full-Text

CRISPR-Cas9: A method for establishing rat models of drug metabolism and pharmacokinetics - ScienceDirect

Therapies targeting DNA and RNA in Huntington's disease - The Lancet Neurology

Phage delivered CRISPR-Cas system to combat multidrug-resistant pathogens in gut microbiome - ScienceDirect

Allogeneic chimeric antigen receptor-T cells with CRISPR-disrupted programmed death-1 checkpoint exhibit enhanced functional fitness - Cytotherapy

The microbiome and host mucosal interactions in urinary tract diseases

Using CRISPR/Cas9 to model human liver disease - ScienceDirect

Mitochondrial medicine in the omics era - The Lancet

Allogeneic chimeric antigen receptor-T cells with CRISPR-disrupted programmed death-1 checkpoint exhibit enhanced functional fitness - Cytotherapy

Advances in multi-omics study of biomarkers of glycolipid metabolism disorder - Computational and Structural Biotechnology Journal

Protective Effect of Natural Products against Huntington's Disease: An Overview of Scientific Evidence and Understanding Their Mechanism of Action